For citations:
Avxentyev N.A., Andreyashkina I.I., Artamonova E.V., Bolotina L.V., Kovalenko E.I., Sisigina N.N. Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literature review. Tumors of female reproductive system. 2024;20(1):64-81. (In Russ.) https://doi.org/10.17650/1994-4098-2024-20-1-64-81
Email this article 